Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,549
Recruiting: 1,935
Ph III recruiting: 225
Growth YoY: +16.5%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 451–500 of 749 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06488222	Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer	recruiting	Phase 2	34	University of FloridaOTHER	1	Mar 11, 2026	clinicaltrials
NCT07142551	Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response	recruiting	Phase 2	60	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	Mar 11, 2026	clinicaltrials